Phase 1Data readout

INCB160058

Myeloproliferative Neoplasms (MPNs)

INCYIncyte Corporation

Expected catalystDecember 31, 2026Company guidance: Dec 31, 2026

Catalyst overview

Event details

Drug or asset: INCB160058
Development stage: Phase 1
Event type: Data readout
Indication: Myeloproliferative Neoplasms (MPNs)

Research summary

What is being tracked?

This catalyst tracks a Phase 1 data readout for INCB160058 in Myeloproliferative Neoplasms (MPNs). The expected timing is based on the latest available company guidance and may change.

Development notes

Ongoing Ph1 trial with proof-of-concept data in H1 2026.

Verification

Primary source

Confirm timing and program details against the company announcement or filing.

Open source

INCB160058

Event details

What is being tracked?

Development notes

Primary source

Related pipeline programs

Olumiant/Baricitinib (JAK Inhibitor)

Zilurgisertib (ALK2 Inhibitor)

Povorcitinib (JAK1)

Povorcitinib (JAK1)